Q3 2017 Concert Pharmaceuticals Inc Earnings Call
Llamada en conferencia Concert Pharmaceuticals Inc
Concert Pharmaceuticals Inc Conference call will be held on 09-nov-2017. During the earnings conference call's session Concert Pharmaceuticals Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Concert Pharmaceuticals Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are a clinical stage biopharmaceutical company applying our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs. Incorporation of deuterium into known molecules has the potential to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Our approach starts with approved drugs, advanced clinical candidates or previously studied compounds that may be improved with deuterium substitution. Our technology provides the opportunity to develop products that may compete with the non-deuterated drug in existing markets or to leverage the known activity of approved drugs to expand into new indications. Our DCE Platform® has broad potential across numerous therapeutic areas. The following table summarizes our diverse clinical pipeline of product candidates. All of these candidates are small molecules designed for oral administration.Leer más Llamada en conferencia